AIM: SLCO1B1 variants are associated with intermediate outcomes that may increase risk of death/myocardial infarction (MI) in statin-treated patients. PATIENTS & METHODS: In high-risk Caucasians undergoing cardiac catheterization, we tested the association between rs4149056/625T>C and rs2306283/492A>G with low-density lipoprotein cholesterol (LDL-c) over 3 years (n = 1402) and death/MI over 6 years (n = 2994), accounting for statin use or type during follow-up. RESULTS: Carriers of the rs4149056 C allele had 6.2 ± 1.7 mg/dl higher LDL-c per C allele (p < 0.001) but were not at higher risk for death/MI (p = 0.9). We found no associations between rs2306283 and LDL-c or death/MI (p > 0.6). CONCLUSION: Functional SLCO1B1 variants are not associated with death/MI in patients commonly treated with statins, despite higher LDL-c in carriers of the rs4149056 C allele.
AIM: SLCO1B1 variants are associated with intermediate outcomes that may increase risk of death/myocardial infarction (MI) in statin-treated patients. PATIENTS & METHODS: In high-risk Caucasians undergoing cardiac catheterization, we tested the association between rs4149056/625T>C and rs2306283/492A>G with low-density lipoprotein cholesterol (LDL-c) over 3 years (n = 1402) and death/MI over 6 years (n = 2994), accounting for statin use or type during follow-up. RESULTS: Carriers of the rs4149056 C allele had 6.2 ± 1.7 mg/dl higher LDL-c per C allele (p < 0.001) but were not at higher risk for death/MI (p = 0.9). We found no associations between rs2306283 and LDL-c or death/MI (p > 0.6). CONCLUSION: Functional SLCO1B1 variants are not associated with death/MI in patients commonly treated with statins, despite higher LDL-c in carriers of the rs4149056 C allele.
Authors: Michael H Davidson; Kevin C Maki; Thomas A Pearson; Richard C Pasternak; Prakash C Deedwania; James M McKenney; Gregg C Fonarow; David J Maron; Benjamin J Ansell; Luther T Clark; Christie M Ballantyne Journal: Am J Cardiol Date: 2005-08-15 Impact factor: 2.778
Authors: C L Shear; F A Franklin; S Stinnett; D P Hurley; R H Bradford; A N Chremos; D T Nash; A Langendorfer Journal: Circulation Date: 1992-04 Impact factor: 29.690
Authors: Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone Journal: Circulation Date: 2004-07-13 Impact factor: 29.690
Authors: Pernette R W de Sauvage Nolting; Rudolf J A Buirma; Barbara A Hutten; John J P Kastelein Journal: Am J Cardiol Date: 2002-07-15 Impact factor: 2.778
Authors: L R Smith; F E Harrell; J S Rankin; R M Califf; D B Pryor; L H Muhlbaier; K L Lee; D B Mark; R H Jones; H N Oldham Journal: Circulation Date: 1991-11 Impact factor: 29.690
Authors: Wei-Qi Wei; Xiaohui Li; Qiping Feng; Michiaki Kubo; Iftikhar J Kullo; Peggy L Peissig; Elizabeth W Karlson; Gail P Jarvik; Ming Ta Michael Lee; Ning Shang; Eric A Larson; Todd Edwards; Christian M Shaffer; Jonathan D Mosley; Shiro Maeda; Momoko Horikoshi; Marylyn Ritchie; Marc S Williams; Eric B Larson; David R Crosslin; Sarah T Bland; Jennifer A Pacheco; Laura J Rasmussen-Torvik; David Cronkite; George Hripcsak; Nancy J Cox; Russell A Wilke; C Michael Stein; Jerome I Rotter; Yukihide Momozawa; Dan M Roden; Ronald M Krauss; Joshua C Denny Journal: Circulation Date: 2018-10-23 Impact factor: 29.690
Authors: Jonathan B Wagner; Susan Abdel-Rahman; Andrea Gaedigk; Roger Gaedigk; Geetha Raghuveer; Vincent S Staggs; Leon Van Haandel; J Steven Leeder Journal: Clin Transl Sci Date: 2020-03-09 Impact factor: 4.689
Authors: Stella Trompet; Iris Postmus; Helen R Warren; Raymond Noordam; Roelof A J Smit; Elizabeth Theusch; Xiaohui Li; Benoit Arsenault; Daniel I Chasman; Graham A Hitman; Patricia B Munroe; Jerome I Rotter; Bruce M Psaty; Mark J Caulfield; Ron M Krauss; Adrienne L Cupples; Wouter J Jukema Journal: Front Pharmacol Date: 2022-01-05 Impact factor: 5.810